Where to buy Erdafitinib more formally

Erdafitinib (Erdafitinib), as a new type of FGFR inhibitor, has been officially launched in China. It is used for the treatment of urothelial cancer (bladder cancer). Specifications include5mg28 tablets, 3mg56 tablets and 4mg*28 tablets. However, due to its short time on the market, it has not yet been included in the scope of medical insurance. If patients want to purchase regular drugs, there are three main ways.

First, the most formal channels are the oncology departments or pharmacies of domestic tertiary hospitals. Since erdafitinib has been approved for marketing in China, patients can purchase it directly through the hospital pharmacy after a doctor issues a prescription. The advantage of this channel is that the source of drugs is reliable, and doctors' guidance and corresponding monitoring services can be obtained.

Second, some patients will choose to purchase original drugs through overseas market channels such as Hong Kong, China. It is understood that Hong Kong pharmacies have formal channels to supply original drugs, but the price is relatively high, reaching more than 20,000 yuan per box. The Hong Kong version of original drugs is consistent with international standards in terms of quality and efficacy, and is suitable for patients who have high requirements for drug formality.

Third, patients with limited financial resources sometimes consider overseas generic versions, such as those from Bangladesh or Laos. These drugs are basically the same as the original drugs in terms of ingredients and dosage, but the price is relatively low, usually ranging from a few hundred yuan to more than 2,000 yuan. However, when purchasing generic drugs, you must pay attention to the legality of the channels and the quality of the drugs, and avoid going through informal intermediaries to avoid risks.

To sum up, when choosing to purchase erdafitinib, patients can consider regular domestic medical institutions, pharmacies in Hong Kong, and overseas generic drug channels. No matter which method is chosen, medication should be taken under the guidance of a doctor and combined with genetic testing results to determine suitability to ensure treatment effectiveness and medication safety.

References：https://www.balversa.com/